Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

SLNOSLNO
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in SOLENO THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of SLNO (SOLENO THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$27.3M

Total Shares Change

-540,296

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$53.01
0
2026-Q1
Increased
1.2M
+6.4%
$41.4M0.0%$37.72
31
2025-Q4
Increased
1.2M
+7.2%
$53.9M0.0%$46.29
32
2025-Q3
Increased
1.1M
+20.2%
$73.4M0.0%$68.16
35
2025-Q2
Increased
902,396
+46.6%
$75.6M0.0%$83.25
41
2025-Q1
Increased
615,736
+2.8%
$44M0.0%$71.99
30
2024-Q4
Increased
599,119
+10.9%
$26.9M0.0%$45.30
32
2024-Q3
Increased
540,296
+10.5%
$27.3M0.0%$49.13
32

Other major holders of SLNO: FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used